Lindsy van der Laan, Dionne Sizoo, Loek J. M. de Heide, André P. van Beek, Marloes Emous
{"title":"Fewer patients with insufficient weight loss after one anastomosis gastric bypass compared to Roux-en-Y gastric bypass after 5 years of follow-up","authors":"Lindsy van der Laan, Dionne Sizoo, Loek J. M. de Heide, André P. van Beek, Marloes Emous","doi":"10.1111/cob.12728","DOIUrl":null,"url":null,"abstract":"<p>This study aims to give a comprehensive overview of the one anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) during 5 years of follow-up in terms of weight loss, the remission of obesity-associated diseases and complications. We performed a retrospective cohort study, with a 1:1 propensity-score matched (PSM) comparison between all adult patients who underwent a primary OAGB or RYGB in 2016. Patients with a body mass index (BMI) ≥50 kg/m<sup>2</sup> were excluded. In total, 372 patients underwent OAGB and 113 patients RYGB. After performing a 1:1 PSM, we obtained two nearly identical cohorts of 113 patients. After OAGB, the percentage of total weight loss (%TWL) was significantly higher during 5 years of follow-up. Also, more patients after OAGB had a successful weight loss (TWL > 20%) after 5 years (86% vs. 72%; <i>p</i> = .019). The remission of obesity-associated diseases and short-term complications did not differ between both procedures. Persistent reflux was the reason for conversion to RYGB in 11.3% of the patients after OAGB. More internal herniations were seen after RYGB (10.4% vs. 1.9%; <i>p</i> = .010). Overall, the proportion of patients with major mid-term complications did not differ between both procedures. In conclusion, OAGB resulted in more weight reduction and especially fewer patients with insufficient weight loss during 5 years of follow-up, while remission of obesity-associated diseases remained the same.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 3","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.12728","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Obesity","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cob.12728","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to give a comprehensive overview of the one anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) during 5 years of follow-up in terms of weight loss, the remission of obesity-associated diseases and complications. We performed a retrospective cohort study, with a 1:1 propensity-score matched (PSM) comparison between all adult patients who underwent a primary OAGB or RYGB in 2016. Patients with a body mass index (BMI) ≥50 kg/m2 were excluded. In total, 372 patients underwent OAGB and 113 patients RYGB. After performing a 1:1 PSM, we obtained two nearly identical cohorts of 113 patients. After OAGB, the percentage of total weight loss (%TWL) was significantly higher during 5 years of follow-up. Also, more patients after OAGB had a successful weight loss (TWL > 20%) after 5 years (86% vs. 72%; p = .019). The remission of obesity-associated diseases and short-term complications did not differ between both procedures. Persistent reflux was the reason for conversion to RYGB in 11.3% of the patients after OAGB. More internal herniations were seen after RYGB (10.4% vs. 1.9%; p = .010). Overall, the proportion of patients with major mid-term complications did not differ between both procedures. In conclusion, OAGB resulted in more weight reduction and especially fewer patients with insufficient weight loss during 5 years of follow-up, while remission of obesity-associated diseases remained the same.
期刊介绍:
Clinical Obesity is an international peer-reviewed journal publishing high quality translational and clinical research papers and reviews focussing on obesity and its co-morbidities. Key areas of interest are: • Patient assessment, classification, diagnosis and prognosis • Drug treatments, clinical trials and supporting research • Bariatric surgery and follow-up issues • Surgical approaches to remove body fat • Pharmacological, dietary and behavioural approaches for weight loss • Clinical physiology • Clinically relevant epidemiology • Psychological aspects of obesity • Co-morbidities • Nursing and care of patients with obesity.